Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Profit After Tax: 2022-2024

Historic Profit After Tax for Addex Therapeutics (ADXN) over the last 3 years, with Dec 2024 value amounting to $8.0 million.

  • Addex Therapeutics' Profit After Tax fell 115.62% to -$2.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$9,430.7 billion, marking a year-over-year decrease of 208.65%. This contributed to the annual value of $8.0 million for FY2024, which is 168.24% up from last year.
  • Latest data reveals that Addex Therapeutics reported Profit After Tax of $8.0 million as of FY2024, which was up 168.24% from -$11.8 million recorded in FY2023.
  • Addex Therapeutics' 5-year Profit After Tax high stood at $8.0 million for FY2024, and its period low was -$21.8 million during FY2022.
  • For the 3-year period, Addex Therapeutics' Profit After Tax averaged around -$8.5 million, with its median value being -$11.8 million (2023).
  • Data for Addex Therapeutics' Profit After Tax shows a peak YoY surged of 168.24% (in 2024) over the last 5 years.
  • Addex Therapeutics' Profit After Tax (Yearly) stood at -$21.8 million in 2022, then spiked by 46.11% to -$11.8 million in 2023, then soared by 168.24% to $8.0 million in 2024.